Neurocognitive Disorders: Clinical Trials

21 trials for Neurocognitive Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 withdrawn. 21 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 421Withdrawn 21

Follow Neurocognitive Disorders: new trials by email Literature Review of Neurocognitive Disorders trials Research Report on Neurocognitive Disorders

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)
Trazodone, Quetiapine, Placebo - Delirium, Morality
Phase 4WithdrawnUniversity of Southern California2028-03-012026-05-04
Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
l-Histidine, Control - Alzheimer Disease
Phase 4WithdrawnWake Forest University Health Sciences2025-04-012025-04-27
Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients
Best Practice, Electronic Health Record Review, Interview - Advanced Malignant Solid Neoplasm, Delirium
Phase 4WithdrawnMayo Clinic2025-02-262025-05-01
Dexmedetomidine Cycling and Sleep in the Pediatric ICU
Dexmedetomidine Hydrochloride - Cycling, Fentanyl - PICU Standard, Dexmedetomidine Hydrochloride - PICU Standard - Critical Illness, Sedation Complication
Phase 4WithdrawnVanderbilt University Medical Center2023-02-202022-05-10
Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults
Ramelteon, Placebo - Delirium in Old Age
Phase 4WithdrawnBrigham and Women's Hospital2019-12-012020-01-22
Effect of Sevoflurane, Propofol and Dexmedetomidine on Delirium & Neuroinflammation in Mechanically Ventilated Patients
Sevoflurane, Propofol, Dexmedetomidine - Delirium
Phase 4WithdrawnMoscow Regional Research and Clinical Institute (MONIKI)2017-09-012019-08-15
Decreasing the Incidence of Delirium After Cardiac Surgery
Benzodiazepine, Fentanyl, Propofol - C.Surgical Procedure; Cardiac, Delirium
Phase 4WithdrawnUniversity of California, Los Angeles2017-08-012018-06-12
Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment
1612 capsule, Placebos - Mild Cognitive Impairment
Phase 4WithdrawnDongzhimen Hospital, Beijing2017-01-012021-03-04
Ramelteon and Citicoline for Delirium
Ramelteon, Citicoline - Delirium
Phase 4WithdrawnUniversity of Texas Southwestern Medical Center2016-07-012017-11-09
Melatonin for Delirium Prophylaxis
Melatonin, Placebo - Delirium
Phase 4WithdrawnUniversity of British Columbia2016-02-012021-10-07
Melatonin for Prevention of Post- Operative Delirium Pilot Study Protocol
Melatonin, Placebo - Delirium
Phase 4WithdrawnLoyola University2015-06-012016-09-16
Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS.
Dexmedetomidine, Propofol - Delirium
Phase 4WithdrawnMoscow Regional Research and Clinical Institute (MONIKI)2015-02-012019-08-14
Use of Dexmedetomidine in Children Undergoing Oral Maxillofacial Surgery to Decrease Emergence Delirium
dexmedetomidine - Delirium
Phase 4WithdrawnShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University2011-06-012017-05-05
Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium
Risperidone, Trazodone, Placebo - Delirium, Agitation
Phase 4WithdrawnRochester General Hospital2011-03-012019-09-10
Once Weekly D-cycloserine for Schizophrenia
D-cycloserine, Placebo - Schizophrenia
Phase 4WithdrawnMassachusetts General Hospital2009-07-012013-11-20
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Methylphenidate, Placebo - Diabetes Mellitus, Alzheimer's Disease
Phase 4WithdrawnUniversity of Nebraska2008-11-182024-09-23
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
ziprasidone, Standard therapy - Psychosis, Agitation
Phase 4WithdrawnGeorge Washington University2008-09-012017-09-25
Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
Donepezil Hydrochloride (Aricept) - Severe Alzheimer's Disease
Phase 4WithdrawnEisai Inc.2008-01-012012-12-10
Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients
Divalproex ER, Quetiapine - Alzheimer's Disease, Dementia
Phase 4WithdrawnUniversity of Cincinnati2006-10-012015-05-27
Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
Amantadine, Placebo - Dementia
Phase 4WithdrawnJohns Hopkins University2005-09-012017-08-14

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Delirium (13)  ·  Alzheimer Disease (5)  ·  Dementia (3)  ·  Cognitive Dysfunction (2)  ·  Mental Disorders (2)  ·  Psychomotor Agitation (2)  ·  Psychotic Disorders (2)  ·  Sleep Initiation and Maintenance Disorders (2)  ·  Behavioral Symptoms (1)  ·  Critical Illness (1)  ·  Diabetes Mellitus (1)  ·  Emergence Delirium (1)  ·  Frontotemporal Dementia (1)  ·  Lethargy (1)  ·  Lymphoma, Follicular (1)

Broader conditions

Mental Disorders (19)  ·  Nervous System Diseases (19)  ·  Neurobehavioral Manifestations (14)  ·  Neurologic Manifestations (14)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Signs and Symptoms (14)  ·  Confusion (13)  ·  Brain Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Neurodegenerative Diseases (6)  ·  Tauopathies (5)  ·  Behavior (3)  ·  Dementia (3)  ·  Aberrant Motor Behavior in Dementia (2)

Interventions

Dexmedetomidine (4)  ·  Propofol (3)  ·  Donepezil (2)  ·  Melatonin (2)  ·  Quetiapine Fumarate (2)  ·  Standard of Care (2)  ·  Trazodone (2)  ·  ramelteon (2)  ·  Amantadine (1)  ·  Benzodiazepines (1)  ·  Cycloserine (1)  ·  Cytidine Diphosphate Choline (1)  ·  Fentanyl (1)  ·  Histidine (1)  ·  Interviews as Topic (1)

Sponsors

Moscow Regional Research and Clinical Institute (MONIKI) (2)  ·  Brigham and Women's Hospital (1)  ·  Dongzhimen Hospital, Beijing (1)  ·  Eisai Inc. (1)  ·  Ever Neuro Pharma GmbH (1)  ·  George Washington University (1)  ·  Johns Hopkins University (1)  ·  Loyola University (1)  ·  Massachusetts General Hospital (1)  ·  Mayo Clinic (1)  ·  Rochester General Hospital (1)  ·  Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)  ·  University of British Columbia (1)  ·  University of California, Los Angeles (1)  ·  University of Cincinnati (1)

Countries

United States (14)  ·  China (2)  ·  Austria (1)  ·  Canada (1)

Top investigators

Catherine M Kuza, MD, FASA (1)  ·  Chiara N Foster, MD (1)  ·  David M Blass, M.D. (1)  ·  Dieter Meier, MD (1)  ·  Donald C Goff, M.D. (1)  ·  E. Sherwood Brown, MD, PhD (1)  ·  Elizabeth B Klerman, M.D.,PhD (1)  ·  Hong Jiang, MD, PHD (1)  ·  Jacques Neelankavil, M.D. (1)  ·  Jinzhou Tian, M.D,PhD (1)  ·  Mindee S Hite, Pharm.D. (1)  ·  Muhammad Aslam, MD (1)  ·  Muralidhara S Rao, MD (1)  ·  Peter KY Chan, MD (1)  ·  Prasad R Padala, M.D. (1)

Results publications

PMID 12075033, PMID 15082703, PMID 15817019, PMID 1593914, PMID 19347026, PMID 19687169, PMID 19865006, PMID 21926597, PMID 22301509, PMID 23182527, PMID 23506796, PMID 25348864, PMID 26077062, PMID 26118922, PMID 6880820

NIH funding

P50MH060450 (1)